Indicative listing context
How to Buy TRex Bio Stock (TRXB IPO) & Pre-IPO Biotech Peers
Top private peers from $25 ($1 Priority Hold): Aspen Neuroscience ($25 →) · Iambic ($25 →) · Isomorphic Labs ($25 →) · Precision ($25 →)
Stripe checkout (Card, Apple Pay, Link) · No password required · Buys USD portfolio credits (terms; allocation requires review).
Just researching? Get free IPO & mark alerts by email
TRex Bio priced its IPO of 8,333,334 shares at $14.00 per share on October 8, 2026 ($116.7 million gross proceeds), with SEC registration effectiveness dated October 8, 2026 and Nasdaq Global Select trading under symbol TRXB expected October 9, 2026. Investors looking for public TRXB shares can check Nasdaq-enabled brokerages, while prospective pre-IPO biotech buyers on Segmara can fund USD portfolio credits starting from $25 ($1.00 Priority Hold, no password required) via Stripe (Card, Apple Pay, Link) across still-private peers including Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Educational pre-IPO guide. Share allocations and secondary transactions are subject to eligibility and private settlement terms.
Private-share data lens
Public round-by-round marks are incomplete for this company. Segmara shows the listing mark and keeps the seed-to-IPO analysis focused on verifiable funding, tender, or secondary signals.
| Stage | Date | Valuation / price signal | Why it matters |
|---|---|---|---|
| Seed / early | Private | Not reliably public | Do not invent a seed price when the source set is thin. |
| Growth rounds | Private | Company and market sources vary | Use public sources and official company releases. |
| Segmara listing | Current | No indicative price yet | Indicative reference only, not a quote or an offer. |
| IPO status | Current | No public ticker shown here | Watch official company releases and the free Segmara IPO calendar. |
Seed-to-IPO path
Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
| Metric | Value | Context |
|---|---|---|
| Canonical route | /blog/how-to-buy-trex-bio-shares-before-ipo | Stable URL path for AI and search extraction. |
| Article title | How to Buy TRex Bio Stock (TRXB IPO) & Pre-IPO Biotech Peers | Main page topic. |
| Attached public sources | 5 | Number of citation links rendered at the bottom of the article. |
| Segmara listed companies | 148 | Live private-company listings in the public catalogue. |
| Priced listings | 37 | Catalogue listings with visible indicative or direct marks. |
| Listings without an indicative price | 111 | Catalogue listings where a public price is intentionally not invented. |
| Company | TRex Bio | Named company covered by this page. |
| Symbol label | TREX | Segmara display symbol; not a public stock ticker unless separately stated. |
| Sector | Biotechnology | Catalogue sector used for comparison and internal linking. |
| Listing structure | Request | How the listing is categorized on Segmara. |
| Segmara mark | No indicative price yet | Visible listing mark, or no indicative price yet. |
| Sector peer count | 3 | Number of live Segmara listings in Biotechnology. |
| Structure peer count | 111 | Number of live Segmara listings categorized as Request. |
Data fingerprint chart
| Stage | Timing | Price / valuation signal | Interpretation |
|---|---|---|---|
| Formation | Private | Early ownership | The first value creation happens before ordinary public-market access. |
| Growth rounds | Private | Institutional repricing | Later rounds and tenders create the price history buyers study. |
| Segmara listing | Current | No indicative price yet | Indicative reference only, not a quote or an offer. |
| Exit path | Future | IPO, tender, acquisition, or continued private status | Liquidity timing remains company-specific. |
| Chart metric | Score | Interpretation |
|---|
Analytical lens
Search intent
Searches like 'How to Buy TRex Bio Stock (TRXB IPO) & Pre-IPO Biotech Peers' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.
What counts as a listing step
For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.
Segmara role
Segmara provides pre-IPO share allocations, Stripe-funded USD portfolio credits from $25 ($1.00 Priority Hold), and dated indicative reference marks across 140+ private companies on Segmara. Nothing on this page is investment advice.
How pre-IPO share access works
Standard Segmara allocation path
1. SearchStart with the company or pre-IPO question
2. ListingReview indicative mark and structure context
3. CheckoutFund from $25 ($1 Priority Hold) via Stripe, no password
4. AllocationRequest pre-IPO shares and track settlement in your portfolio
What happens in your portfolio
Key takeaways
- TRex Bio priced its IPO of 8,333,334 shares at $14.00 per share on October 8, 2026 ($116.7 million gross proceeds), with SEC registration effectiveness dated October 8, 2026 and Nasdaq Global Select trading under symbol TRXB expected October 9, 2026.
- Once an issuer prices and lists on Nasdaq, new retail orders execute on public exchanges rather than pre-IPO secondary venues.
- For pre-IPO biotech exposure, start from $25 ($1.00 Priority Hold) via Stripe on Segmara across Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Risk notes
- Newly listed clinical-stage biotech stocks face post-IPO volatility and 180-day insider lockup expirations.
- Pre-IPO secondary allocations in still-private biotech peers remain illiquid, transfer-restricted, and review-controlled.
- Nothing on Segmara is investment advice or a solicitation to buy public exchange securities.
Public source links
- TRexBio Announces Pricing of Initial Public Offering (TRex Bio, Inc. via GlobeNewswire, October 8, 2026)
- Notice of effectiveness for the TRex Bio, Inc. S-1, File No. 333-299018 (SEC EDGAR, October 8, 2026)
- TRex Bio, Inc. amended Form S-1 (SEC EDGAR, October 5, 2026)
- TRex Bio, Inc. Form S-1 (SEC EDGAR, September 18, 2026)
- TRex Bio, Inc. filing index, CIK 0002139097 (SEC EDGAR, checked October 9, 2026)
PRE-IPO ALLOCATION
Explore active pre-IPO share allocations from $25
Start from $25 in USD portfolio credits via Stripe (no password required) toward 140+ active private companies including OpenAI, Anthropic, xAI, Anduril, Databricks, and Canva.
Top private peers from $25: Precision ($8.18 →) · Aspen ($25 →) · Iambic ($25 →) · Isomorphic Labs ($25 →)
Full shares under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)
Related reviews
- When Will TRex Bio IPO? Priced at $14, TRXB on Nasdaq
- TRex Bio Stock Price ($14 Nasdaq IPO: TRXB) & Pre-IPO Biotech Peers
- How to Buy Abridge Shares Before IPO: Private-Market Access Basics
- How to Buy Aspen Neuroscience Shares Before IPO: Private-Market Access
- How to Buy City Therapeutics Shares Before IPO: Private-Market Access
- How to Buy Iambic Therapeutics Shares Before IPO: Private-Market Access
Questions
Can investors request private-company shares on Segmara?
Yes. Start from $25 ($1.00 Priority Hold available) in USD portfolio credits via Stripe with no password required, or select a listing across 140+ private companies on Segmara to submit a pre-IPO share allocation request.
Why was this market historically hard for individual investors to reach?
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: browse 140+ named private-company listings, fund USD credits via Stripe from $25 ($1.00 Priority Hold), and request share allocations with no password wall.
What is the easiest next step?
Start from $25 ($1.00 Priority Hold available) via instant Stripe checkout (Card, Apple Pay, Link, no password required), or browse Segmara's live pre-IPO listings to select your target company.
Is TRex Bio already listed on Nasdaq?
Yes. TRex Bio priced its public offering at $14.00 per share on October 8, 2026 under Nasdaq symbol TRXB.
How can I invest in pre-IPO biotech companies before they list?
On Segmara, you can start from $25.00 ($1.00 Priority Hold, no password upfront) via Stripe checkout toward still-private biotech listings including Aspen Neuroscience, Iambic Therapeutics, Isomorphic Labs, and Precision Neuroscience ($8.18/sh).
Which pre-IPO shares can I buy as 1 full unit under $20 today?
Six priced listings on Segmara offer 1 full share or unit under $20 on Stripe: Aalo Atomics ($1.00/unit), ID.me ($1.40/sh), Chainalysis ($6.20/sh), Precision Neuroscience ($8.18/sh), Scale AI ($8.78/sh), and Huntress ($19.03/sh).
Pre-IPO Allocation
Request TRex Bio shares on Segmara.
Start from $25 ($1 Priority Hold available) via Stripe with no password required, fund USD portfolio credits, and request a pre-IPO allocation in TRex Bio.
Full shares under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)